VerifiedRx

Vizient Center for Pharmacy Practice Excellence

Delivering short doses of insight for hospitals’ frontline pharmacy professionals, Vizient pharmacy leader Gretchen Brummel brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence. read less
Health & FitnessHealth & Fitness

Episodes

Vizient Pharmacy Market Outlook – Winter 2024
Feb 1 2024
Vizient Pharmacy Market Outlook – Winter 2024
Vizient publishes our Pharmacy Market Outlook twice a year. The outlook features drug price projections and key market insights to help support members' strategic planning. Drs. Jeni Hayes and Amanda Frick, both Senior Clinical Managers for Market Intelligence, join Gretchen Brummel, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program host to give an early look.   Guest speakers:  Jeni Hayes, PharmD, MSPharm, BCPS Senior Clinical Manager, Market Intelligence Vizient    Amanda Frick, PharmD, BCPS Senior Clinical Manager, Market Intelligence Vizient    Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence     Show Notes:  [00:42-03:08] Areas of focus 2024 highlighted in this Pharmacy Market Outlook  [03:09-05:35] The table of new and noteworthy approvals and some of the approvals that you were most excited to see [05:36-07:05] Some drugs that you're looking forward to seeing approved in 2024 [07:06-08:25] What are you hearing from our members on their experiences and challenges with cellular and gene therapies? [08:26-10:57] What else is going on in the specialty space [10:58-12:14] Specialty pharmacy sustained growth that we've seen for patients in the acute care space [12:15 -14:39] What's the projection for this edition [14:40-14:24] Where listeners go if they want more detailed information on the outlook   Links | Resources:  Vizient Pharmacy Market Outlook provider link: Click Here Vizient Pharmacy Market Outlook highlights public version: Click Here   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
“Standardized” Stewardship – Navigating the new TJC Standards for Antimicrobial Stewardship
Jan 23 2024
“Standardized” Stewardship – Navigating the new TJC Standards for Antimicrobial Stewardship
Anti-Microbial Stewardship Programs are critical to optimizing utilization, mitigating resistance, and improving patient outcomes. These programs are continuously refined, and recent updates to The Joint Commission standards provide an opportunity to enhance our approach. Dr. Ripal Jariwala, Infectious Diseases Clinical Pharmacist, and Assistant Clinical Professor at the University of California San Francisco, and Dr. Ethan A. Smith, Clinical Infectious Diseases Specialist at Ronald Reagan UCLA Medical Center, join host Gretchen Brummel to discuss the revised standards and implications for pharmacy.   Guest speakers:  Dr. Ripal Jariwala, PharmD, BCIDP, AAHIVP Infectious Diseases Clinical Pharmacist, and Assistant Clinical Professor UCSF    Dr. Ethan A. Smith, PharmD., BCIDP Clinical Infectious Diseases Specialist Ronald Reagan UCLA Medical Center   Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence   Show Notes:  [01:01-01:47] The guests background  [01:48-02:58] Brief update of the recent changes to Antimicrobrial Stewardship [02:59-07:35] Interpreting the new EP-10 Joint Commission standard about financial and IT resources [07:36-11:23] The current landscape on FTEs to support antimicrobial stewardship [11:24-15:13] EP15 on evidence-based use of antibiotics considerations [15:14-18:27] How do you approach meeting the revised standard on data collection analysis and recording for EP20 [18:28 -21:23] Other standards besides the joint commission standards that people need to be aware of [21:24-23:34] Other related work going on in this space [23:35-26:54] More information or other resources to find those items about antimicrobial stewardship   Links | Resources: Knowledge on the Go Podcast: Updates for Antimicrobial Stewardship Standards VHA directive 1031: Click here CDC Updates on Antibiotic Stewardship and Required Antimicrobial Use and Resistance Reporting – On Demand: CDC Updates OnDemand2023 document and Click here to play recording   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
DSCSA “Go”
Jan 16 2024
DSCSA “Go”
The Drug Supply Chain Security Act was designed to ensure the safety and integrity of our nation’s drug supply and prevent counterfeit medications from entering the market.  In this third of a four-part series, Carolyn Liptak and Dwight deVera share their insights on FDA final DSCSA guidance with host Gretchen Brummel and how member providers can be ready.     Guest speakers:  Carolyn Liptak, MBA, BSPharm  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence  Dwight deVera VP of Healthcare Intelligence  Inmar Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:44-01:14] Dwight’s background  [01:15-02:20] What Carolyn and Dwight are hearing in the market [02:21-03:39] Carolyn and Dwight’s thoughts on taking that stabilization period as an opportunity to wait [03:40-05:22] Meeting the deadline on GLN’s [05:23-06:59] Issue with having duplicate GLNs for a single site [07:00-07:43] How Dwight is advising clarity on a timeline with the quarantine process [07:44-09:23] Other tools our members need to know about if they have a suspect product investigation [09:24-10:30] Comments and advice from Dwight and Carolyn   Links | Resources:  Drug Supply Chain Security Act (DSCSA) portal FDA Requests Feedback on Enhanced Drug Distribution Security Implementation Progress Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act (DSCSA) Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act – Compliance Policies   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
Rollout Strategy Vexing: Pediatric RSV prevention strategy implementation challenges
Dec 26 2023
Rollout Strategy Vexing: Pediatric RSV prevention strategy implementation challenges
RSV infections are not new and have devastating impacts. The recent advent of new prevention strategies has renewed the focus on the disease with a hopeful outlook. For the last 25 years, the only FDA approved product preventing RSV, lower respiratory tract disease, was palivizumab or Synagis, a monoclonal antibody indicated for use in high risk infants children and administered intramuscularly monthly throughout the RSV season. In May, the first ever RSV vaccines were approved, Arexvy and Abrysvo. These two new RSV vaccines were approved for use in adults greater than or equal to 60 years of age. In August this year, one of the RSV vaccines, Abrysvo, also received approval for expanded use for maternal vaccination to prevent RSV lower respiratory tract disease in infants. Nirsevimab or Beyfortus, a new long-acting monoclonal antibody, was approved in July for prevention of RSV lower respiratory tract disease in infants and children. Compared with palivizumab, nirsevimab is indicated for a much broader patient population including recommended use in all infants less than eight months of age, born during or entering their first RSV season. The rollout of nirsevimab has proved challenging due to supply shortages, among other factors. Today we discuss the new RSV prevention strategies, focusing on the pediatric patient population, as well as the recent shortages with nirsevimab. Dr. Deb Bondi, Dr. Nikolai Dahl, as well as Dr. Kyle Hoelting from Vizient join guest host Vizient’s John Schoen for today's podcast.   Guest speakers:  Deb Bondi, PharmD, FCCP, BCPS, BCPPS Pediatric Clinical Coordinator, NICU Clinical Pharmacy Specialist, and PGY2 Pediatric Pharmacy Residency Program Director UChicago Medicine, Comer Children's Hospital   Nikolai Dahl, PharmD Utilization and Formulary Program Manager John Muir Health   Kyle Hoelting, PharmD, BCPS Senior Clinical Manager of Drug Shortages and Drug Information Vizient Center for Pharmacy Practice Excellence    Host:  John Schoen, PharmD, BCPS  Senior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence   Show Notes:  [02:39-04:09] Update on where everything currently stands with the Nirsevimab supply and what led to the shortage [04:10-05:01] Information on whether or not there's going to be additional supply of either the 50 mg or 100 mg syringes later this season [05:02-06:01] Resources related to mitigating this nirsevimab shortages [06:02-10:29] What University of Chicago and John Muir Health are doing with these new RSV vaccines and the new monoclonal antibody, Beyfortus [10:30-13:15] Formulary decisions University of Chicago and John Muir Health make around nirsevimab and palivizumab [13:16-15:24] Organizational preference for the maternal RSV vaccine or nirsevimab [15:25-20:33] Other logistical issues with either nirsevimab or the maternal RSV vaccines, such us scope of practice consideration, stocking of the VFC product in patient education, et cetera [20:34-22:01] Payment of billing issues either University of Chicago or John Muir Health experienced for either nirsevimab or the maternal RSV vaccine [22:02-24:57] Clinical pearls or advice related to these new prevention strategies   Links | Resources: Vizient member RSV resources RSV vaccines in adults side-by-side comparison RSV monoclonal antibodies in pediatrics side-by-side comparison FAQ pediatric RSV prevention strategies Minute Market Insight on nirsevimab shortage Mitigation strategy on nirsevimab shortage   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
DSCSA “Set”
Nov 21 2023
DSCSA “Set”
The Drug Supply Chain Security Act was designed to ensure the safety and integrity of our nation’s drug supply and prevent counterfeit medications from entering the market.  In this second of a four-part series, Carolyn Liptak, Eric Marshall, and Josh Bolin share their insights on FDA final DSCSA guidance with host Gretchen Brummel and how member providers can be ready.     Guest speakers:  Carolyn Liptak, MBA, BSPharm  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Eric Marshall  Principal at Leavitt Partners Executive Director of the Partnership for DSCSA Governance   Josh Bolin  Associate Executive Director, Government Affairs and Innovation National Association of Boards of Pharmacy   Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence   Show Notes:  [00:55-02:27] Josh and Eric’s backgrounds  [02:28-03:36] What we need to know for DSCSA implementation on November 27th [03:37-05:10] NABP view of FDA DSCSA guidance [05:11-07:27] PDG view of FDA DSCSA guidance [07:28-08:23] Next steps for DSCSA compliance that our members should be focusing on [08:24-11:11] Why it is important to have documented policies and procedures to ensure compliance [11:12-12:28] Where organizations that need help with creating those policies and procedures go [12:29-15:24] How the 24-hour time frame is defined since medications are not traced within a hospital [15:25-18:17] DSCSA regulatory responsibilities are shared between the FDA and state boards of pharmacy [18:18-21:26] How we account for traceability across state lines and what should we expect in the future [21:27-23:49] Some complexities here especially around 340B medications [23:50-24:54] Where verification has to occur: data flowing from the manufacturer to the covered entity, but the product is flowing to the actual contracted pharmacy [24:55-26:30] Last thoughts on how our members can be set for DSCSA   Links | Resources: Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act (DSCSA) Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act – Compliance Policies NABP Links: https://nabp.pharmacy https://nabp.pharmacy/pulse     Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
Insights Into Oncology Drug Shortages
Oct 4 2023
Insights Into Oncology Drug Shortages
Vizient recently published a paper on the impact of oncology drug shortages for patients and provider members. Drs. Carina Dolan and Jeni Hayes share their insights of the causes and how to improve things moving forward with host Gretchen Brummel.     Guest speakers:  Carina Dolan, PharmD, MS, BCOP AVP of Market Intelligence  Vizient Pharmacy Solutions  Jeni Hayes, PharmD, MSPharm, BCPS  Senior Clinical Manager, Market Intelligence Vizient Pharmacy Solutions   Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence    Show Notes:  [00:48-01:52] Drugs included in shortage of cancer drugs report [01:53-02:58] How we define drug shortages [02:59-04:03] Specific event that precipitated the oncology drug shortage [04:04- 05:39] Overall impact on the sales for these medications [05:40-07:25] What demand are we seeing for these medications [07:26-08:23] How Vizient Pharmacy Program participants have been affected [08:24-09:59] Looking at the shortage severity and its impact on Vizient Pharmacy Program participants [10:06-12:13] How we improve things moving forward [12:14-13:49] What front line pharmacy staff should know about these shortages   Links | Resources:  Evaluating the impact of the oncology drug shortage white paper Evaluating the impact of the oncology drug shortage fact sheet Vizient: Lack of Information Across Supply Chain Exacerbating Oncology Drug Shortage press release Webinar: Oncology insights: new therapies and drug shortages Drug shortage: Oncology agents mitigation strategy   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
Mastering Mindfulness and Meditation to Mitigate Medication Error Risk: Promoting a Present and Resilient Workforce
Sep 12 2023
Mastering Mindfulness and Meditation to Mitigate Medication Error Risk: Promoting a Present and Resilient Workforce
Medication safety is top of mind for all pharmacy professionals, and being present and resilient is integral to safe and effective patient care. Lisa Hanlon, Medication Safety and Compliance specialist at Penn State Health, Hershey Medical Center and Heart Rhythm Meditation practitioner joins Gretchen Brummel to walk us through the methods, science and reasoning behind mindfulness and meditation as key tools for providing a safe patient care environment and improving our own wellbeing.   Guest speakers: Lisa M Hanlon, BS Pharm, RPh Medication Safety and Compliance Specialist Penn State Health, Milton S. Hershey Medical Center   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:45 - 02:13] Lisa’s background [02:14 - 3:57] How Lisa started meditation and applied it in her work [3:58 - 5:37] How Lisa connects mindfulness and medication safety [5:38 - 8:06] The differences between meditation and mindfulness [8:06 - 9:47] Key things Lisa shares about meditation and mindfulness [9:48 - 12:04] Examples of things that we could avoid just by being more present in our work [12:05 - 13:11] Lisa’s recommendations on how to get started with a practice [13:12 - 13:51] What Lisa wants frontline pharmacy staff to know about meditation   Links | Resources: iamHeart website Connecting With Heart - iamHeart   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed
It takes a village! Advancing pharmacy practice through excellence in public policy, Part 2
Aug 22 2023
It takes a village! Advancing pharmacy practice through excellence in public policy, Part 2
Vizient Pharmacy Vision Awards celebrate the values and achievements of our pharmacy members. 3 winners of the 2022 Excellence in Public Policy Award, Jacqueline Blake, Drs. Leeann Miller and Marjorie Lazarre, all from Yale New Haven Health, join Gretchen Brummel, Pharmacy Executive Director in the Center for Pharmacy Practice Excellence at Vizient, and your program host to discuss advancing pharmacy practice through public policy.   Guest speakers: LeeAnn Miller, PharmD, MS, CPEL Vice President, Chief Pharmacy Officer Yale New Haven Health   Marjorie Lazarre, PharmD, MBA  Associate Chief Pharmacy Officer Corporate Pharmacy Services Yale New Haven Health   Jacqueline Blake, Esq Senior Government Relations Officer Yale New Haven Health   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:42-01:48] Amber, Marie and Steph backgrounds [01:49-03:11] Why advocacy is so important [03:12 - 05:06] How to justify focusing on advocacy [05:07- 06:36] How to get started in advocacy [06:37-08:31] Getting away from, "We've always done it this way [08:31 - 12:43] Changes in advocacy over their careers [12:44 - 13:54] Maintaining momentum [13:55 - 17:33] Real world wins and examples of successes [17:34 - 21:05] Partners to propel their messages forward [21:06 - 23:34] Things folks should look out for [23:35 - 25:42] Their advice around advocacy [25:43 - 26:25] Future plans   Links | Resources: Vizient Pharmacy Vision Awards Overview document About the program 2022 award winners   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed
It takes a village! Advancing pharmacy practice through excellence in public policy, Part 1
Aug 15 2023
It takes a village! Advancing pharmacy practice through excellence in public policy, Part 1
Vizient Pharmacy Vision Awards celebrate the values and achievements of our pharmacy members. 3 winners of the 2022 Excellence in Public Policy Award, Drs. Amber Zaniewski, Steph Luon, and Marie Renauer, all from Yale New Haven join Gretchen Brummel, Pharmacy Executive Director in the Center for Pharmacy Practice Excellence at Vizient, and your program host to discuss advancing pharmacy practice through public policy.   Guest speakers: Steph Luon, PharmD, BCPS, BCACP Manager, Ambulatory Clinical Pharmacy Services Yale New Haven Hospital   Marie M. Renauer, PharmD, MBA, BCACP  Associate Director, Ambulatory Clinical Pharmacy Services Yale New Haven Hospital   Amber Zaniewski, PharmD, BCPS, BCCCP System Director, Clinical Pharmacy Services Yale New Haven Hospital, Corporate Pharmacy Services   Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Director Vizient Center for Pharmacy Practice Excellence   Show Notes: [00:43-01:28] Amber, Marie and Steph backgrounds [01:29-5:17] Identifying the need for public policy changes [5:18 - 06:36] Key stakeholders they partnered with [06:37-11:58] How the process unfolded and results [11:59-12:55] Challenges along the way [12:56 - 15:59] Positive impacts [16:00 - 18:12] Advice for Pharmacy Professionals [18:13 - 18:41] Future plans   Links | Resources: Vizient Pharmacy Vision Awards Overview document About the program 2022 award winners   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed
Pharmacy Market Outlook Summer 2023
Aug 2 2023
Pharmacy Market Outlook Summer 2023
Jeni Hayes and Shannon Holden share insights on the Summer 2023 Vizient Pharmacy Market Outlook with host Gretchen Brummel. Jeni, and Shannon discuss the outlook’s projection, and ways that frontline staff can use the report.   Guest speakers:  Jeni Hayes, PharmD, MSPharm, BCPS  Senior Clinical Manager for Pharmacy Outcomes   Vizient Center for Pharmacy Practice Excellence  Shannon Holden, PharmD, BCACP, CACP  Senior Clinical Manager for Ambulatory  Vizient Center for Pharmacy Practice Excellence  Moderator:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence  Show Notes:  [00:45-01:37] Enhancements and improvements in the Pharmacy Market Outlook this summer  [01:38-02:24] Hot topics for this edition of the PMO  [02:25-03:36] Expectations of adalimumab biosimilars  [03:37-5:03] Spending impact on medications to treat autoimmune and inflammatory conditions  [5:04-6:50] Insight into the new cardio-metabolic and neurology sections  [6:51-8:43] Should we expect to see continued growth in spending on oncology agents  [8:44-10:31] Final projection number for this edition  [10:32-12:38] How frontline staff can use PMO in their work  [12:39-13:05] Where to get more detailed information on PMO  Links | Resources:  Vizient Pharmacy Market Outlook Member link: Click Here Vizient Pharmacy Market Outlook highlights public version: Click Here  Semaglutide: weighing the pros and cons for use in pediatrics  Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Stitcher Android RSS Feed